Back to search

Article

Antibody Response After COVID-19 mRNA Vaccination in Relation to Age, Sex, and Side Effects

2021-04-30

Abstract excerpt

Background: Although the SARS-CoV2 mRNA vaccines have proven high efficacy in clinical trials, there is limited data on the impact of age, sex, and side effects on vaccine-induced immune responses.<br><br>Methods: We studied the development of SARS-CoV-2 S-RBD antibodies after the Comirnaty mRNA vaccine in 118 healthy volunteers and correlated immune response with age, sex, and side effects of the vaccinations.<br...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f5577d5-3fce-55d2-b745-91c8ff39ff84
DOI
10.2139/ssrn.3831845
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antibody Response After COVID-19 mRNA Vaccination in Relation to Age, Sex, and Side EffectsDOI 10.2139/ssrn.3831845
Declined Antibody Responses to COVID-19 mRNA Vaccine within First Three MonthsSemantic proximity
Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic reviewSemantic proximity
Waning of SARS-CoV-2 vaccine-induced immunity: A systematic review and secondary data analysisSemantic proximity
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationSemantic proximity
Demographic and Clinical Factors Associated With Anti–SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine DosesSemantic proximity
Effectiveness of Mrna Booster Vaccination Against Mild and Severe COVID-19 During Delta and Omicron Variant Circulation in Germany: An Analysis of National Surveillance DataSemantic proximity
COVID‐19 Vaccine Efficacy and the Evidence on BoostersSemantic proximity
Immunogenicity and Safety of COVID-19 Booster Vaccination: A Real-World Clinical Trial to Identify the Best Vaccination StratagySemantic proximity
Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S VaccinesSemantic proximity
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.SSemantic proximity
Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countriesSemantic proximity
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kineticsSemantic proximity
Select a neighboring publication to make it the new centre.